Results
Latest quarterly results
Companies that reported quarterly results recently, newest first. Each row compares the reported quarter with the same quarter a year earlier. Figures in USD; revenue and net income in millions.
SectorAll 3892Healthcare 878Financial Services 629Technology 560Industrials 517Consumer Cyclical 330Basic Materials 232Energy 196Communication Services 168Real Estate 161Consumer Defensive 134Utilities 87
| Company | Sector | Reported | Quarter | Revenue | Rev. YoY | Net income | NI YoY | EPS | EPS YoY | Op. margin | Margin chg. | Market cap |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NBIXNeurocrine Biosciences, Inc. | Healthcare | Nov 2 | Sep '26 | $1.12B | +41.3% | $207M | −1.4% | $1.96 | −3.9% | 29.5% | −0.6 pp | $16.8B |
| JAZZJazz Pharmaceuticals plc | Healthcare | Nov 2 | Sep '26 | $1.24B | +10.4% | −$483M | −292.4% | −$7.48 | −283.3% | -33.3% | −38.4 pp | $15.5B |
| BMRNBioMarin Pharmaceutical Inc. | Healthcare | Nov 2 | Sep '26 | $1.02B | +32.1% | −$123M | n/m | −$0.63 | n/m | -8.0% | −2.0 pp | $11.3B |
| TEMTempus AI, Inc. | Healthcare | Nov 2 | Sep '26 | $412M | +23.4% | −$15.0M | n/m | −$0.08 | n/m | -13.8% | +4.4 pp | $11.2B |
| HNGEHinge Health, Inc. | Healthcare | Nov 2 | Sep '26 | $235M | +52.6% | $57.0M | n/m | $0.66 | n/m | 21.4% | +25.4 pp | $9.3B |
| KRYSKrystal Biotech, Inc. | Healthcare | Nov 2 | Sep '26 | $127M | +29.6% | $63.0M | −20.3% | $2.05 | −22.9% | 55.9% | +13.6 pp | $8.8B |
| AXSMAxsome Therapeutics, Inc. | Healthcare | Nov 2 | Sep '26 | $260M | +52.0% | −$13.0M | n/m | −$0.25 | n/m | -4.3% | +22.7 pp | $7.2B |
| TVTXTravere Therapeutics, Inc. | Healthcare | Nov 2 | Sep '26 | $225M | +36.4% | −$52.0M | −300.0% | −$0.55 | −320.0% | -30.3% | −45.5 pp | $4.9B |
| CRSPCRISPR Therapeutics AG | Healthcare | Nov 2 | Sep '26 | $13.0M | +1,200% | −$111M | n/m | −$1.15 | n/m | — | — | $3.9B |
| INSPInspire Medical Systems, Inc. | Healthcare | Nov 2 | Sep '26pending | $207M† | −8.1% | — | — | — | — | — | — | $1.7B |
| RXRXRecursion Pharmaceuticals, Inc. | Healthcare | Nov 2 | Sep '26 | $19.0M | +280.0% | −$119M | n/m | −$0.22 | n/m | -664.0% | — | $1.7B |
| SIBNSI-BONE, Inc. | Healthcare | Nov 2 | Sep '26 | $56.0M | +14.3% | −$4.0M | n/m | −$0.08 | n/m | -7.8% | +3.3 pp | $1.0B |
| SPTXSeaport Therapeutics, Inc. | Healthcare | Nov 2 | Sep '26 | $0.0M | — | −$26.0M | — | −$0.49 | — | — | — | $973M |
| HSTMHealthStream, Inc. | Healthcare | Nov 2 | Sep '26pending | $83.3M† | +9.6% | — | — | — | — | — | — | $845M |
| SNDXSyndax Pharmaceuticals, Inc. | Healthcare | Nov 2 | Sep '26 | $83.0M | +80.4% | −$49.0M | n/m | $0.00 | n/m | -50.3% | +74.9 pp | $828M |
| BVSBioventus Inc. | Healthcare | Nov 2 | Sep '26 | $142M | +2.2% | $6.0M | +100.0% | $0.08 | +60.0% | 6.8% | −1.9 pp | $726M |
| TCMDTactile Systems Technology, Inc. | Healthcare | Nov 2 | Sep '26 | $92.0M | +7.0% | $7.0M | −12.5% | $0.31 | −13.9% | 10.4% | −2.3 pp | $584M |
| CERSCerus Corporation | Healthcare | Nov 2 | Sep '26 | $58.0M | +9.4% | −$1.0M | n/m | $0.00 | n/m | 0.7% | −1.7 pp | $384M |
| EBSEmergent BioSolutions Inc. | Healthcare | Nov 2 | Sep '26 | $110M | −52.4% | $0.0M | −100.0% | $0.00 | −100.0% | 0.0% | −33.2 pp | $288M |
| ABBVAbbVie Inc. | Healthcare | Oct 30 | Sep '26 | $17.40B | +10.3% | $4.22B | +2,168% | $2.38 | +2,280% | 36.0% | +23.9 pp | $517.7B |
| AZNAstraZeneca PLC | Healthcare | Oct 30 | Sep '26pending | $16.21B† | +6.7% | — | — | — | — | — | — | $282.7B |
| REGNRegeneron Pharmaceuticals, Inc. | Healthcare | Oct 30 | Sep '26pending | $5.12B† | +36.3% | — | — | — | — | — | — | $99.1B |
| BTSGBrightSpring Health Services, Inc. | Healthcare | Oct 30 | Sep '26 | $4.21B | +26.4% | $100M | +78.6% | $0.45 | +73.1% | 3.8% | +1.2 pp | $13.9B |
| OGNOrganon & Co. | Healthcare | Oct 30 | Sep '26 | $1.57B | −1.7% | $164M | +2.5% | $0.60 | −1.6% | 23.2% | +0.8 pp | $3.7B |
| AUPHAurinia Pharmaceuticals Inc | Healthcare | Oct 30 | Sep '26 | $84.0M | +15.1% | $32.0M | 0.0% | $0.23 | 0.0% | 42.3% | +1.8 pp | $2.1B |
| IRMDiRadimed Corporation | Healthcare | Oct 30 | Sep '26 | $24.0M | +14.3% | $7.0M | +16.7% | $0.51 | +18.6% | 33.6% | +1.4 pp | $1.1B |
| VORVor Biopharma Inc. | Healthcare | Oct 30 | Sep '26 | $0.0M | n/m | −$87.0M | n/m | −$1.45 | n/m | — | — | $985M |
| OABIOmniAb, Inc. | Healthcare | Oct 30 | Sep '26 | $4.0M | n/m | −$16.0M | n/m | −$0.12 | n/m | -404.9% | — | $737M |
| MNDRMobile-health Network Solutions | Healthcare | Oct 30 | Sep '26pending | $3.0M† | n/m | — | — | — | — | — | — | $22,882 |
| LLYEli Lilly and Company | Healthcare | Oct 29 | Sep '26pending | $24.40B† | +38.6% | — | — | — | — | — | — | $1.33T |
| MRKMerck & Company, Inc. Common Stock (new) | Healthcare | Oct 29 | Sep '26pending | $18.09B† | +5.2% | — | — | — | — | — | — | $353.4B |
| GILDGilead Sciences, Inc. | Healthcare | Oct 29 | Sep '26pending | $8.30B† | +6.8% | — | — | — | — | — | — | $211.2B |
| BMYBristol-Myers Squibb Company | Healthcare | Oct 29 | Sep '26pending | $13.07B† | +6.9% | — | — | — | — | — | — | $125.4B |
| SYKStryker Corporation | Healthcare | Oct 29 | Sep '26pending | $6.52B† | +7.6% | — | — | — | — | — | — | $120.9B |
| RMDResMed Inc. | Healthcare | Oct 29 | Sep '26 | $1.42B | +5.9% | $418M | +19.8% | $2.92 | +23.2% | 32.0% | −1.4 pp | $33.5B |
| ILMNIllumina, Inc. | Healthcare | Oct 29 | Sep '26pending | $1.17B† | +7.7% | — | — | — | — | — | — | $30.6B |
| DXCMDexCom, Inc. | Healthcare | Oct 29 | Sep '26pending | $1.34B† | +11.2% | — | — | — | — | — | — | $30.6B |
| WSTWest Pharmaceutical Services, Inc. | Healthcare | Oct 29 | Sep '26 | $875M | +8.8% | $214M | +52.9% | $3.02 | +56.5% | 30.6% | +9.0 pp | $28.8B |
| INSMInsmed Incorporated | Healthcare | Oct 29 | Sep '26 | $524M | +269.0% | −$100M | n/m | −$0.46 | n/m | -17.0% | +240.1 pp | $26.7B |
| INCYIncyte Corporation | Healthcare | Oct 29 | Sep '26 | $1.56B | +14.0% | −$785M | −285.1% | −$3.86 | −282.9% | -45.5% | −77.1 pp | $24.3B |
| THCTenet Healthcare Corporation | Healthcare | Oct 29 | Sep '26 | $6.28B | +18.7% | $1.00B | +192.4% | $12.41 | +221.5% | 27.9% | +11.1 pp | $22.4B |
| ALNYAlnylam Pharmaceuticals, Inc. | Healthcare | Oct 29 | Sep '26pending | $1.46B† | +16.7% | — | — | — | — | — | — | $21.0B |
| EXELExelixis, Inc. | Healthcare | Oct 29 | Sep '26 | $659M | +10.2% | $218M | +12.4% | $0.85 | +21.4% | 40.8% | +1.2 pp | $17.2B |
| BBIOBridgeBio Pharma, Inc. | Healthcare | Oct 29 | Sep '26 | $353M | +191.7% | −$57.0M | n/m | −$0.42 | n/m | -3.3% | +117.0 pp | $15.0B |
| BAXBaxter International Inc. | Healthcare | Oct 29 | Sep '26pending | $2.98B† | +5.0% | — | — | — | — | — | — | $13.3B |
| PENPenumbra, Inc. | Healthcare | Oct 29 | Sep '26 | $410M | +15.5% | $42.0M | −8.7% | $1.07 | −8.5% | 12.4% | −1.4 pp | $12.6B |
| DVADaVita Inc. | Healthcare | Oct 29 | Sep '26 | $3.58B | +4.6% | $223M | +48.7% | $3.40 | +66.7% | 13.9% | −0.8 pp | $10.9B |
| KYMRKymera Therapeutics, Inc. | Healthcare | Oct 29 | Sep '26 | $0.0M | n/m | −$132M | n/m | −$1.32 | n/m | — | — | $10.4B |
| ATRAptarGroup, Inc. | Healthcare | Oct 29 | Sep '26 | $1.02B | +6.0% | $33.0M | −74.2% | $0.51 | −73.4% | 13.3% | −1.2 pp | $8.9B |
| SUPNSupernus, Inc. | Healthcare | Oct 29 | Sep '26 | $227M | +18.2% | $21.0M | n/m | $0.35 | n/m | 9.3% | +40.7 pp | $6.0B |
- Report dates come from the earnings calendar (dates loaded Oct 4 to Dec 9); figures come from the quarterly statements stored for each company. Click a ticker for its full statements.
- YoY compares the reported quarter with the same quarter a year earlier. n/m (not meaningful) means the year-earlier figure was zero or negative, so a percentage change would not describe it. Margin change is in percentage points.
- pending: the company has reported, but that quarter is not in our statements yet. Revenue marked † is the announced figure from the earnings calendar; the other columns fill in once the statements update.
Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.